Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Delivra Health Brands Inc. DHBUF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
45/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Delivra Health Brands Inc. (DHBUF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.13. It has a SharesGrow Score of 42/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $13M, +18.2%/yr average growth. Net income is $874,054 (loss), growing at +157.9%/yr. Net profit margin is -6.5% (negative). Gross margin is 50.7% (+18.7 pp trend).

Balance sheet: total debt is $2M against $3M equity (Debt-to-Equity (D/E) ratio 0.68, moderate). Current ratio is 3.66 (strong liquidity). Debt-to-assets is 22%. Total assets: $10M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 90/100 (Pass), Past 25/100 (Fail), Health 50/100 (Partial), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

DHBUF SharesGrow Score Overview

45/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — DHBUF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
90/100
DHBUF: +18.2%/yr revenue is, +157.9%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
DHBUF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet DHBUF: Debt-to-Equity (D/E) ratio 0.68 (moderate), Current ratio is 3.66 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
DHBUF: Gross margin is 50.7% (+18.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
DHBUF: Net profit margin is -6.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0601-0.2612
Volume110
Avg Volume (30D)1.33K
Market Cap$4.2M
Beta (1Y)0.80
Share Statistics
EPS (TTM)-0.03
Shares Outstanding$31.26M
IPO Date2017-05-02
Employees22
CEOGord Davey
Financial Highlights & Ratios
Revenue (TTM)$13.37M
Gross Profit$6.78M
EBITDA$143.96K
Net Income$-874.05K
Operating Income$-617.71K
Total Cash$3.3M
Total Debt$2.11M
Net Debt$-1.19M
Total Assets$9.61M
Price / Earnings (P/E)-4.8
Price / Sales (P/S)0.31
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA24703H2019

Price Chart

Track all markets on TradingView
DHBUF
Delivra Health Brands Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.06 52WK RANGE 0.26

People Also View

SSIC
SSIC
Silver Spike Investment Corp.
$10.74
+1.27%
 GDNSF
GDNSF
Goodness Growth Holdings, Inc.
$0.45
+0.00%
 CANSF
CANSF
Willow Biosciences Inc.
$0.11
+0.00%
 CXXIF
CXXIF
C21 Investments Inc.
$0.31
+15.12%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 AVCNF
AVCNF
Avicanna Inc.
$0.12
+3.42%
 DLTNF
DLTNF
Delta 9 Cannabis Inc.
$0.01
-1.95%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message